PUVA therapy: Current concerns in Japan

Journal of Dermatological Science

Volumn 19, Issue 2, 1999, Pages 89-105

  Danno, Kiichiro ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Carcinogenesis; Mechanism; Psoralen; Skin disease; Treatment; Ultraviolet

Indexed keywords

CLINICAL PROTOCOL; CONFERENCE PAPER; HUMAN; JAPAN; PRIORITY JOURNAL; PSORIASIS; PUVA; SKIN CANCER; SKIN DISEASE; TREATMENT INDICATION; ULTRAVIOLET RADIATION;

HUMANS; JAPAN; METHOXSALEN; PHOTOSENSITIZING AGENTS; PUVA THERAPY; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0033018538     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(98)00065-6     Document Type: Conference Paper

References (138)

1. Parrish J.A., Fitzpatrick T.B., Tanenbaum L., Pathak M.A. Photochemotherapy of psoriasis with oral methoxsalen and long-wave ultraviolet light. New Engl J Med. 291:1974;1207-1212.
2. Mizuno N., Ohno M., Uematsu S. 8-Methoxypsoralen phototherapy of psoriasis vulgaris (in Japanese). Jpn J Dermatol. 85:1975;577-586.
3. Meffert H., Andersen K.E., Sönichsen N. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time. Photodermatol Photoimmunol Photomed. 1:1984;191-194.
4. Petrozzi J.W., Kaidbey K.M., Kligman A.M. Topical methoxsalen and blacklight in the treatment of psoriasis. Arch Dermatol. 113:1997;292-296.
5. Danno K., Toda K., Ishida H., Horio T. Topical methoxsalen followed immediately by long-wave UV irradiation: a preliminary report on the treatment of psoriasis. Arch Dermatol. 118:1982;471-478.
6. Danno K., Horio T., Ozaki M., Imamura S. Topical 8-methoxypsoralen photochemotherapy of psoriasis: a clinical study. Br J Dermatol. 108:1983;519-524.
7. Lowe N.J., Weingarten D., Bourget T., Moy L.S. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol. 14:1986;754-760.
8. Guidelines of care for phototherapy and photochemotherapy. J Am Acad Dermatol. 31:1994;643-648.
9. British photodermatology group guidelines for PUVA. Br J Dermatol. 130:1994;246-255.
10. Wagner G., Hofmann C., Busch U., Schmid J., Plewig G. 8-MOP plasma levels in PUVA problem cases with psoriasis. Br J Dermatol. 101:1979;285-292.
11. Gazith J., Schalla W., Bauer E., Schaefer H. 8-methoxypsoralen (8-MOP) in human skin: penetration kinetics. J Invest Dermatol. 71:1978;126-130.
12. Horio T., Miyauchi H., Yamawaki M., Yoshimura M., Sasaki H. Photophysical properties of fluorescent ultraviolet light sources: blacklight and sunlamp (in Japanese). Jpn J Dermatol. 105:1995;1845-1849.
13. Danno K. Treatment of psoriasis: Phototherapy (in Japanese). Monthly Book Derma. 2:1997;63-68.
14. Hirokawa M., Wada T., Kinouchi M., Sakai H., Hashimoto Y., Tsutsui M., Iizuka H. The bath-PUVA therapy for psoriasis vulgaris (in Japanese). Jpn J Clin Dermatol. 49:1995;849-851.
15. Arao T., Nogita T., Nogami R. UVB therapy for psoriasis vulgaris (in Japanese). Hifuka Mook. 2:1985;191-195.
16. Noda R., Danno K., Horio T., Imamura S. Comparison between photochemotherapy and ultraviolet-B therapy in the treatment of psoriasis (in Japanese). Jpn J Clin Dermatol. 41:1987;31-36.
17. Coven T.R., Burack L.H., Gilleaudeau P., Keogh M., Ozawa M., Krueger J.G. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 133:1997;1514-1522.
18. Kiriyama T., Danno K., Uehara M. Combination of topical tacalcitol and PUVA for psoriasis vulgaris. J Dermatol Treat. 8:1997;62-64.
19. 3 (in Japanese). Jpn J Clin Dermatol. 50(suppl. 5):1996;129-132.
20. Hecker D., Lebwohl M. Topical calcipotriene in combination with UVB phototherapy. Int J Dermatol. 36:1997;302-303.
21. Yokoyama M., Yagi H., Danno K., Ogawa M. Retinoid and PUVA combination therapy for psoriasis (in Japanese). Acta Dermatol (Kyoto). 81:1986;529-534.
22. Takashima A., Sunohara A., Matsunami E., Mizuno N. Comparison of therapeutic efficacy of topical PUVA, oral etretinate and combined PUVA and etretinate for the treatment of psoriasis and development of PUVA lentigines and antinuclear antibodies. J Dermatol. 15:1988;473-479.
23. Kobayashi H., Yasuda H., Furuya K., Sato H., Matsumura T., Ohkawara A. PUVA and RePUVA therapy for psoriasis vulgaris (in Japanese). Rinsho Derma (Tokyo). 33:1991;1025-1029.
24. Yaguchi H., Ogawa H. Treatment of psoriasis with low-dose etretinate and PUVA therapy (in Japanese). Jpn J Dermatol. 107:1997;443-447.
25. Tokura Y., Edelson R.L., Gasparro F.P. Formation and removal of 8-MOP-DNA photoadducts in keratinocytes: effects of calcium concentration and retinoids. J Invest Dermatol. 96:1991;942-949.
26. Stern R.S. Risk assessment of PUVA and cyclosporine. Arch Dermatol. 125:1989;545-547.
27. González E. PUVA for psoriasis. Dermatol Clin. 13:1995;851-866.
28. Momtaz-T K., Fitzpatrick T.B. Modification of PUVA. Dermatol Clin. 13:1995;867-873.
29. Morison W.L., Parrish J.A., Fitzpatrick T.B. Oral psoralen photochemotherapy of atopic eczema. Br J Dermatol. 98:1978;25-30.
30. Yoshiike T., Aikawa Y., Sindhvananda J., Ogawa H. A proposed guideline for psoralen photochemotherapy (PUVA) with atopic dermatitis: successful therapeutic effect on severe and intractable cases. J Dermatol Sci. 5:1993;50-53.
31. Yoshiike T., Sindhvananda J., Aikawa Y., Nakajima S., Ogawa H. Topical psoralen photochemotherapy for atopic dermatitis: evaluation of two therapeutic regimens for inpatients and outpatients. J Dermatol. 18:1991;201-205.
32. Suto H., Yoshiike T., Aikawa Y., Kawamoto T., Ogawa H. Combination of photochemotherapy (PUVA) with short-term oral administration of corticosteroid in patients with atopic dermatitis (in Japanese). Jpn J Dermatol. 108:1998;1155-1162.
33. Danno K., Utani A., Ohta M., Ohno S. Photochemotherapy of atopic dermatitis: favorable effect on severe itching (in Japanese). Jpn J Clin Dermatol. 45:1991;529-533.
34. Horio T. PUVA therapy for atopic dermatitis: is it a therapeutic alternative to topical corticosteroids? (in Japanese). Jpn J Dermatol. 106:1996;1808-1810.
35. Jekler J., Larkö O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. J Am Acad Dermatol. 22:1990;49-53.
36. Krutmann J., Diepgen T.L., Luger T.A., Grabbe S., Meffert H., Sönnichsen N., Czech W., Kapp A., Stege H., Grewe M., Schöpf E. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol. 38:1998;589-593.
37. Gilchrest B.A., Parrish J.A., Tanenbaum L., Haynes H.A., Fitzpatrick T.B. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer. 38:1976;683-689.
38. Roenigk H.H. Jr Photochemotherapy for mycosis fungoides. Arch Dermatol. 113:1977;1047-1051.
39. Lowe N.J., Cripps D.J., Dufton P.A., Vickers C.F.H. Photochemotherapy for mycosis fungoides: a clinical and histological study. Arch Dermatol. 115:1979;50-53.
40. Briffa D.V., Warin A.P., Harrington C.I., Bleehen S.S. Photochemotherapy in mycosis fungoides: a study of 73 patients. Lancet. 2(8185):1980;49-53.
41. Powell F.C., Spiegel G.T., Muller S.A. Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA). Mayo Clin Proc. 59:1984;538-546.
42. Horio T., Yamawaki M., Nishitani T., Ohnuki M., Iba S. Systemic PUVA therapy for tumor-stage mycosis fungoides (in Japanese). Lymphomas Skin. 17:1998;97-99.
43. Miyagawa F., Danno K., Hirota Y., Sugiura H., Sakurai K., Fujii N., Uehara M. Oral PUVA therapy for cutaneous T cell lymphomas (in Japanese). Lymphomas Skin. 17:1998;100-103.
44. Hönigsmann H., Brenner W., Rauschmeier W., Konrad K., Wolff K. Photochemotherapy for cutaneous T cell lymphoma. J Am Acad Dermatol. 10:1984;238-245.
45. Herrmann J.J., Roenigk H.H. Jr, Hurria A., Kuzel T.M., Samuelson E., Rademaker A.W., Rosen S.T. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol. 33:1995;234-242.
46. Swanbeck G., Roupe G., Sandström M.H. Indications of a considerable decrease in the death rate in mycosis fungoides by PUVA treatment. Acta Derm Venereol (Stockh). 74:1994;465-466.
47. Nakamura M., Kobayashi S., Matsubara K., Tanaka T., Furukawa F., Imamura S. The effects of non-interval PUVA therapy on the plaque stage of mycosis fungoides. J Dermatol. 22:1995;196-200.
48. Ramsay D.L., Lish K.M., Yalowitz C.B., Soter N.A. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol. 128:1992;931-933.
49. Horio T., Taniguchi S., Hashimoto M., Komura J., Okamoto H., Taki J., Miyachi Y. Photochemotherapy for mycosis fungoides (in Japanese). Acta Dermatol (Kyoto). 74:1979;187-193.
50. Holloway K.B., Flowers F.P., Ramos-Caro F.A. Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol. 27:1992;367-378.
51. Zic J.A., Stricklin G.P., Greer J.P., Kinney M.C., Shyr Y., Wilson D.C., King L.E. Jr Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy. J Am Acad Dermatol. 35:1996;935-945.
52. Maekawa Y. Extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma and progressive systemic sclerosis (in Japanese). Jpn J Clin Dermatol. 45(suppl. 5):1991;181-186.
53. Parrish J.A., Fitzpatrick T.B., Shea C., Pathak M.A. Photochemotherapy of vitiligo: use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Arch Dermatol. 112:1976;1531-1534.
54. Hamada T., Hayashi Y. PUVA therapy for vitiligo vulgaris (in Japanese). Hifubyoh Shinryoh. 7:1985;333-336.
55. Horio T. Photochemotherapy of vitiligo vulgaris (in Japanese). Rinsho Derma (Tokyo). 33:1991;1099-1102.
56. Grimes P.E. Vitiligo: an overview of therapeutic approaches. Dermatol Clin. 11:1993;325-338.
57. Takiwaki H., Kanno Y., Tsuda H., Yamamoto T. A non-standard method of topical PUVA therapy for vitiligo vulgaris (in Japanese). Rinsho Derma (Tokyo). 39:1997;1491-1494.
58. Claudy A.L., Gagnaire D. PUVA treatment of alopecia areata. Arch Dermatol. 119:1983;975-978.
59. Hatamochi A., Ueki H. PUVA therapy for alopecia areata (in Japanese). Rinsho Derma (Tokyo). 24:1982;305-309.
60. Rook A.H., Freundlich B., Jegasothy B.V., Perez M.I., Barr W.G., Jimenez S.A., Rietschel R.L., Wintroub B., Kahaleh M.B., Varga J., Heald P.W., Steen V., Massa M.C., Murphy G.F., Perniciaro C., Istfan M., Ballas S.K., Edelson R.L. Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial. Arch Dermatol. 128:1992;337-346.
61. Extracorporeal photopheresis for progressive systemic sclerosis: results of a multicenter trial (in Japanese). Nishinihon J Dermatol. 57:1995;127-135.
62. Kerscher M., Volkenandt M., Meurer M., Lehmann P., Plewig G., Roecken M. Treatment of localized scleroderma with PUVA bath photochemotherapy. Lancet. 343:1994;1233.
63. Kanekura T., Fukumaru S., Matsushita S., Terasaki K., Mizoguchi S., Kanzaki T. Successful treatment of scleroderma with PUVA therapy. J Dermatol. 23:1996;455-459.
64. Yamaguchi K., Takeuchi I., Yoshii N., Gushi A., Kanekura T., Kanzaki T. The discrepancy in hardness between clinical and histopathological findings in localized scleroderma treated with PUVA. J Dermatol. 25:1998;544-546.
65. Izeki H., Akamatsu H., Morita T., Isei T., Horio T. Oral PUVA therapy for scleroderma, abstracted (in Japanese). Jpn J Dermatol. 108:1998;558.
66. Stege H., Berneburg M., Humke S., Klammer M., Grewe M., Grether-Beck S., Boedeker R., Diepgen T., Dierks K., Goerz G., Ruzicka T., Krutmann J. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol. 36:1997;938-944.
67. Imura M., Ohta M., Toda K. Treatment of parapsoriasis en plaque with oral 8-methoxypsoralen PUVA therapy (in Japanese). Rinsho Derma (Tokyo). 24:1982;1341-1346.
68. Nemoto H., Horiuchi C., Sato N., Nagao S., Iijima S. PUVA therapy for parapsoriasis en plaque (in Japanese). Hifubyoh Shinryoh. 7:1985;341-344.
69. Mizuno N., Uematsu S., Ohno M. 8-Methoxypsoralen phototherapy of pustulosis palmaris et plantaris (in Japanese). Jpn J Dermatol. 85:1975;595-597.
70. Miura T., Kuramochi M. PUVA therapy of pustulosis palmaris et plantaris (in Japanese). Rinsho Derma (Tokyo). 33:1991;1119-1123.
71. Matsunami E., Takashima A., Mizuno N., Jinno T., Ito H. Topical PUVA, etretinate and combined PUVA and etretinate for palmoplantar pustulosis: comparison of therapeutic efficacy and the influences of tonsillar and dental focal infections. J Dermatol. 17:1990;92-96.
72. Clark A.R., Jorizzo J.L., Fleischer A.B. Papular dermatitis (subacute prurigo, 'itchy red bump' disease): pilot study of phototherapy. J Am Acad Dermatol. 38:1998;929-933.
73. Yamauchi T., Tamamori T., Yoshizawa N., Matsumoto K., Takigawa M., Yamada M. PUVA therapy for chronic prurigo (in Japanese). Acta Dermatol (Kyoto). 81:1986;545-549.
74. Vaatainen N., Hannuksela M., Karvonen J. Local photochemotherapy in nodular prurigo. Acta Derm Venereol (Stockh). 59:1979;544-547.
75. Honig B., Morison W.L., Karp D. Photochemotherapy beyond psoriasis. J Am Acad Dermatol. 31:1994;775-790.
76. Epstein J.H., Fukuyama K. A study of 8-methoxypsoralen (8-MOP) induced phototoxic effects on mammalian epidermal macromolecular synthesis in vivo. J Invest Dermatol. 54:1970;350-351.
77. Walter J.F., Voorhees J.J., Kelsey W.H., Duell E.A. Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol. 107:1973;861-865.
78. Scherer R., Kern B., Braun-Falco O. UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen. Br J Dermatol. 97:1977;519-528.
79. Okamoto H., Horio T. The effect of 8-methoxypsoralen and long-wave ultraviolet light on Langerhans cell. J Invest Dermatol. 77:1981;345-346.
80. Horio T., Okamoto H. The mechanisms of inhibitory effect of 8-methoxypsoralen and long-wave ultraviolet light on experimental contact sensitization. J Invest Dermatol. 78:1982;402-406.
81. Horio T., Okamoto H. Immunologic unresponsiveness induced by topical application of hapten to PUVA-treated skin in guinea pigs. J Invest Dermatol. 80:1983;90-93.
82. Kripke M.L., Morison W.L., Parrish J.A. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol. 81:1983;87-92.
83. Horio T., Okamoto H., Hashimoto H., Mishima M., Yamawaki M., Danno K. The action mechanism of phototherapy with emphasis on photoimmunologic effects (in Japanese). Skin Res. 39:1997;218-224.
84. Pathak M.A., Joshi P.C. The nature and molecular basis of cutaneous photosensitivity reactions to psoralens and coal tar. J Invest Dermatol. 80:1983;66s-74.
85. Averbeck D. Recent advances in psoralen phototoxicity mechanism. Photochem Photobiol. 50:1989;859-882.
86. Danno K., Horio T. In vitro PUVA radiation abolishes fluorescent staining with epidermal cell and basement membrane zone markers. Br J Dermatol. 113:1985;391-396.
87. Laskin J.D., Lee E., Laskin D.L., Gallo M.A. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding. Proc Natl Acad Sci USA. 83:1986;8211-8215.
88. Kajita S., Iizuka H., Hashimoto Y., Ohkawara A. Topical PUVA treatment increases epidermal beta-adrenergic adenylate cyclase responsiveness. Br J Dermatol. 114:1986;413-418.
89. Danno K., Yoneda K., Horio T. PUVA irradiation restores altered binding patterns of lectins in psoriatic epidermis. Arch Dermatol. 122:1986;772-778.
90. Moscicki R.A., Morison W.L., Parrish J.A., Bloch K.J., Colvin R.B. Reduction of the fraction of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psoralen/ultraviolet-A radiation (PUVA). J Invest Dermatol. 79:1982;205-208.
91. Baker B.S., Swain A.F., Griffiths C.E.M., Leonard J.N., Fry L., Valdimarsson H. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin Exp Immunol. 61:1985;526-534.
92. Vallat V.P., Gilleaudeau P., Battat L., Wolfe J., Nabeya R., Heftler N., Hodak E., Gottlieb A.B., Krueger J.G. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med. 180:1994;283-296.
93. Prens E., Debets R., Hegmans J. T lymphocytes in psoriasis. Clin Dermatol. 13:1995;115-129.
94. Okamoto H., Takigawa M., Horio T. Alteration of lymphocyte functions by 8-methoxypsoralen and long-wave ultraviolet light radiation: suppressive effect of PUVA on T-lymphocyte migration in vitro. J Invest Dermatol. 84:1985;203-205.
95. Okamoto H., Horio T., Maeda M. Alteration of lymphocyte functions by 8-methoxypsoralen and long-wave ultraviolet radiation. II. The effect of in vivo PUVA on IL-2 production. J Invest Dermatol. 89:1987;24-26.
96. Neuner P., Charvat B., Knobler R., Kirnbauer R., Schwarz A., Luger T.A., Schwarz T. Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UVA. Photochem Photobiol. 59:1994;182-188.
97. Mizuno N., Enami H., Esaki K. Effect of 8-methoxypsoralen plus UVA on psoriasis leukotactic factor. J Invest Dermatol. 72:1979;64-66.
98. Aubin F., Kripke M.L., Ullrich S.E. Activation of keratinocytes with psoralen plus UVA radiation induces the release of soluble factors that suppress delayed and contact hypersensitivity. J Invest Dermatol. 97:1991;995-1000.
99. Danno K. Immunomodulatory effect by ultraviolet light: dual regulation of cutaneous immune cell functions. Acta Dermatol (Kyoto). 87:1992;575-585.
100. Danno K. Action mechanisms of phototherapy: dual effects by ultraviolet radiation (in Japanese). Hifubyoh Shinryoh. 16:1994;679-684.
101. Yamawaki M., Futamura S., Horio T., Asada Y. Alterations of cell adhesion molecules in psoriatic lesions after PUVA therapy (in Japanese). Jpn J Dermatol. 104:1994;959-966.
102. Sayeed Q.K., Danno K., Horiguchi Y., Imamura S. Lectin staining of the endothelial cell membrane is more sensitive to ultraviolet radiation than the epidermal cell staining in guinea-pig skin. J Dermatol Sci. 5:1993;190-196.
103. Petzelbauer P, Stingl G, Wolff K, Volc-Platzer B. Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol 1991;96:362-9.
104. Danno K., Kaji A., Mochizuki T. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments. J Dermatol Sci. 13:1996;49-55.
105. Guo Z., Okamoto H., Danno K., Imamura S. The effects of non-interval PUVA treatment on Langerhans cells and contact hypersensitivity. J Dermatol Sci. 3:1992;91-96.
106. Aikawa Y., Yoshiike T., Kawamoto T., Nishimura K., Kawai H., Ogawa H. Indication of PUVA on atopic dermatitis and effects on variable parameters (in Japanese). Jpn J Dermatol. 102:1992;991-994.
107. Danno K., Toda K., Horio T. The effect of 8-methoxypsoralen plus longwave ultraviolet light (PUVA) radiation on mast cells: PUVA suppresses degranulation of mouse skin mast cells induced by compound 48/80 or concanavalin-A. J Invest Dermatol. 85:1985;110-114.
108. Toda K.-I., Danno K., Tachibana T., Horio T. Effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells. II. In vitro PUVA inhibits degranulation of rat peritoneal mast cells induced by compound 48/80. J Invest Dermatol. 87:1986;113-116.
109. Sugiura H., Maeda T., Uehara M. Mast cell invasion of peripheral nerve in skin lesions of atopic dermatitis. Acta Derm Venereol (Stockh). Suppl. 176:1992;74-76.
110. Danno K. Action mechanisms of ultraviolet radiation therapy: the effect on immediate-type skin inflammation. Skin Res. 30:1988;599-609.
111. Danno K., Sayeed Q.K., Horiguchi Y., Imamura S. Ultraviolet radiation abolishes cutaneous nerve stainings with two axon-specific antibodies in guinea-pig skin. Arch Dermatol Res. 284:1993;460-465.
112. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., Vonderheid E., Knobler R., Wolff K., Plewig G., McKiernan G., Christiansen I., Oster M., Hönigsmann H., Wilford H., Kokoschka E., Rehle T., Perez M., Stingl G., Laroche L. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. New Engl J Med. 316:1987;297-303.
113. Asadullah K., Friedrich M., Döcke W.-D., Jahn S., Volk H.-D., Sterry W. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma. J Invest Dermatol. 108:1997;743-747.
114. Prinz B., Behrens W., Hölzle E., Plewig G. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: the Düsseldorf and Munich experience. Arch Dermatol Res. 287:1995;621-626.
115. Yoo E.K., Rook A.H., Elenitsas R., Gasparro F.P., Vowels B.R. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol. 107:1996;235-242.
116. Miracco C., Rubegni P., De Aloe G., D'Ascenzo G., Mazzatenta C., De Santi M.M., Fimiani M. Extracorporeal photochemotherapy induces apoptosis of infiltrating lymphoid cells in patients with mycosis fungoides in early stages: a quantitative histological study. Br J Dermatol. 137:1997;549-557.
117. Ortonne J.P., MacDonald D.M., Micoud A., Thivolet J. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol. 101:1979;1-12.
118. Cohen S.R., Burkholder D.E., Varga J.M., Carter D.M., Bartholomew J.C. Cell cycle analysis of cultured mammalian cells after exposure to 4,5′,8-trimethylpsoralen and long-wave ultraviolet light. J Invest Dermatol. 76:1981;409-413.
119. Epstein J.H. Photocarcinogenesis, skin cancer and aging. J Am Acad Dermatol. 9:1983;487-502.
120. Roelandts R. Mutagenicity and carcinogenicity of methoxsalen plus UVA. Arch Dermatol. 120:1984;662-669.
121. Nataraj A.J., Wolf P., Cerroni L., Ananthaswamy N. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen+UVA (PUVA). J Invest Dermatol. 109:1997;238-243.
122. Kripke M.L., Morison W.L., Parrish J.A. Induction and transplantation of murine skin cancers induced by methoxsalen plus ultraviolet (320-400 nm) radiation. J Natl Cancer Inst. 68:1982;685-690.
123. Bridges B., Strauss G. Possible hazards of photochemotherapy for psoriasis. Nature. 283:1980;523-524.
124. Studniberg H.M., Weller P. PUVA, UVB, psoriasis and nonmelanoma skin cancer. J Am Acad Dermatol. 29:1993;1013-1022.
125. Stern R.S., Laird N., Melski J., Parrish J.A., Fitzpatrick T.B., Bleich H.L. Cutaneous squamous cell carcinoma in patients treated with PUVA. New Engl J Med. 310:1984;1156-1161.
126. Stern R.S., Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol. 91:1988;120-124.
127. Stern R.S., Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer. 73:1994;2759-2764.
128. Henseler T., Christophers E., Hönigsmann H., Wolff K. Skin tumors in the European PUVA study: eight-year follow-up of 1643 patients treated with PUVA for psoriasis. J Am Acad Dermatol. 16:1987;108-116.
129. McKenna K.E., Patterson C.C., Handley J.H., McGinn S., Allen G. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol. 134:1996;639-642.
130. Torinuki W., Tagami H. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. J Am Acad Dermatol. 18:1988;1278-1281.
131. Takashima A., Matsunami E., Yamamoto K., Kitajima S., Mizuno N. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients. Photodermatol Photoimmunol Photomed. 7:1990;218-221.
132. Kobayashi H., Ohkawara A. Long-term side effects of PUVA therapy (in Japanese). Jpn J Clin Dermatol. 48(suppl. 5):1994;144-148.
133. Yoshitake M., Anekohji K. Basal cell epithelioma in a patient treated with phototherapy for psoriasis (in Japanese). Rinsho Derma (Tokyo). 36:1994;307-310.
134. Aoyama Y., Seishima M., Mori S., Yanagihara M., Yamamoto A., Yoneda K. Multiple lentigo maligna in a patient treated with phototherapy for psoriasis vulgaris (in Japanese). Hifubyoh Shinryoh. 16:1994;125-128.
135. Furuki H., Maekawa Y., Nogami R. Actinic keratosis in a patient with vitiligo vulgaris undergoing PUVA therapy (in Japanese). Rinsho Derma (Tokyo). 37:1995;1636-1637.
136. Sato Y., Yanadori A., Yamakage A., Yamazaki S. A summary of PUVA therapy for psoriasis vulgaris in recent 20 years focusing on a case with side effect (in Japanese). Jpn J Clin Dermatol. 50:1996;673-677.
137. Uehara K., Kamiyama T., Maruno M., Hagiwara K., Tohyama K., Takamiyagi A., Uezato H., Nonaka S. A case of squamous cell carcinoma arising from psoriasis vulgaris after long-term phototherapy (in Japanese). Nishinihon J Dermatol. 59:1997;373-377.
138. Takeda H., Mitsuhashi Y., Kondo S. Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy. J Am Acad Dermatol. 38:1998;268-270.